Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.

The vitamin E analogue, α-tocopherol succinate (α-TOS), has a broad anti-tumor effect. α-TOS can induce cancer cells apoptosis and suppress tumor growth by targeting mitochondria. Low bioavailability of α-TOS is the major problem encountered with formulation development. In our study, α-TOS nanoemulsion (α-TOS-NE) was demonstrated as a new drug delivery system of α-TOS to increase the bioavailability. MTT-based cytotoxicity assay and mitochondrial membrane potential (ΔY) were performed on human breast cancer cell lines MCF-7 and human oral epithelial cancer cell lines KB to evaluate in vitro anticancer efficacy of α-TOS-NE. In comparison with free α-TOS, α-TOS-NE exhibited a stronger cytotoxicity and decreased ΔΨ. Pharmacokinetic profiles of I.V. α-TOS-NE group, I.P. α-TOS-NE group, and I.P. free α-TOS group (7% DMSO/93% PEG) were drawn. First of all, nanoemultion (NE) enables the I.V. injection of α-TOS, make it possible to be an I.V. preparation. Second, compare to the I.P. free α-TOS group, I.P. α-TOS-NE group had a higher bioavailability. Thus, NE improved the strong anti-cancer efficacy of α-TOS while increasing its in vivo bioavailability in rats. In conclusion, our laboratory-made NE was a safe drug delivery system for clinical trials and could be a promising formulation for α-TOS by I.V administration.

[1]  S. Yuk,et al.  Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. , 2004, International journal of pharmaceutics.

[2]  Xiu-fang Wang,et al.  Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. , 2007, Molecular aspects of medicine.

[3]  P. Witting,et al.  α-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop , 2005, Journal of Biological Chemistry.

[4]  L. Gluud,et al.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. , 2012, The Cochrane database of systematic reviews.

[5]  H. Cai,et al.  Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo , 2008, Clinical Cancer Research.

[6]  Jizomoto Hiroaki,et al.  pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate , 1994 .

[7]  R. Moreno-Sánchez,et al.  Targeting of cancer energy metabolism. , 2009, Molecular nutrition & food research.

[8]  J. Ly,et al.  The mitochondrial membrane potential (Δψm) in apoptosis; an update , 2003, Apoptosis.

[9]  Xiu-fang Wang,et al.  Molecular mechanism of ‘mitocan’‐induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl‐2 family proteins , 2006, FEBS letters.

[10]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[11]  A. López‐Malo,et al.  The Role of Alpha Tocopheryl Succinate (α-TOS) as a Potential Anticancer Agent , 2014, Nutrition and cancer.

[12]  Guoying Zhang,et al.  Rationally Engineering Phototherapy Modules of Eosin-Conjugated Responsive Polymeric Nanocarriers via Intracellular Endocytic pH Gradients. , 2015, Bioconjugate chemistry.

[13]  R. Moreno-Sánchez,et al.  Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II* , 2010, The Journal of Biological Chemistry.

[14]  Jerry M. Adams,et al.  Ways of dying: multiple pathways to apoptosis. , 2003, Genes & development.

[15]  D. Green,et al.  The machinery of programmed cell death. , 2001, Pharmacology & therapeutics.

[16]  Xiu-fang Wang,et al.  Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. , 2006, Biochemical and biophysical research communications.

[17]  K. Fukuzawa,et al.  Cytotoxicity of alpha-tocopheryl succinate, malonate and oxalate in normal and cancer cells in vitro and their anti-cancer effects on mouse melanoma in vivo. , 2005, Journal of nutritional science and vitaminology.

[18]  Simone Mocellin,et al.  Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities , 2007, Medicinal research reviews.

[19]  M. Luyckx,et al.  Stability, compatibility and plasticizer extraction of miconazole injection added to infusion solutions and stored in PVC containers. , 1995, Journal of pharmaceutical and biomedical analysis.

[20]  J. Neuzil,et al.  Vitamin E analogues and immune response in cancer treatment. , 2007, Vitamins and hormones.

[21]  B. Zhivotovsky,et al.  Involvement of Ca2+ and ROS in α‐tocopheryl succinate‐induced mitochondrial permeabilization , 2010, International journal of cancer.

[22]  J. Neuzil,et al.  Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity , 2003, British Journal of Cancer.

[23]  Yan Zhao,et al.  Vitamin E analogues as anticancer agents: Lessons from studies with α‐tocopheryl succinate , 2006 .

[24]  H. Rosing,et al.  Influence of Cremophor EL on the quantification of paclitaxel in plasma using high-performance liquid chromatography with solid-phase extraction as sample pretreatment. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[25]  D. Mcclements,et al.  Inhibition of β-carotene degradation in oil-in-water nanoemulsions: influence of oil-soluble and water-soluble antioxidants. , 2012, Food chemistry.

[26]  K. Watabe,et al.  Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis , 2006, International journal of cancer.

[27]  K. Pundarikakshudu,et al.  Preparation and evaluation of transnasal microemulsion of carbamazepine , 2013 .

[28]  Yan Zhao,et al.  Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside? , 2009, Molecular nutrition & food research.

[29]  G. Zhai,et al.  Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation. , 2014, International journal of pharmaceutics.

[30]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[31]  D. Bearss,et al.  α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells , 2004, Cancer Immunology, Immunotherapy.

[32]  L. Gerweck,et al.  The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics. , 2001, Cancer research.

[33]  M. Malafa,et al.  Vitamin E succinate inhibits colon cancer liver metastases. , 2002, The Journal of surgical research.

[34]  V. Labhasetwar,et al.  Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[35]  J. Martinou,et al.  Cytochrome c release from mitochondria: all or nothing , 2000, Nature Cell Biology.

[36]  O. Glatter,et al.  Lipoprotein-associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells , 2000 .